Cultured human glomerular mesangial cells express the C5a receptor

Kidney International

Volumn 54, Issue 5, 1998, Pages 1542-1549

  Braun, Michael ^a   Davis III, Alvin E ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Cell injury; Complement cascade; Glomerulonephritis; Mesangial proliferation; Monocyte chemoattractant protein 1; Platelet derived growth factor; rC5a

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRAL RED; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; IMMUNE INJURY; IMMUNOFLUORESCENCE; MESANGIUM CELL; MITOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031786533     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00155.x     Document Type: Article

References (42)

1. GOLDSTEIN IM: Complement: biologically active products, in Inflammation Basic Principles and Clinical Correlates, edited by GALLIN JI, GOLDSTEIN IM, SYNDERMAN R, New York, Raven Press, 1992. pp 63-80
2. TACK BF, MORRIS SC, PRAHL JW: Fifth component of human complement: Purification from plasma and polypeptide structure. Biochemistry 18:1490-1497, 1979
3. GERARD C, GERARD NP: C5a anaphylatoxin and its seven transmembrane-segmented receptor. Ann Rev Immunol 12:775-808, 1994
4. WFTSEL RA: Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 7:48-53, 1995
5. HAVILAND DL, MCCOY RL, WHITFHEAD WT, AKAMA H, MOLMENTI EP, BROWN A, HAVILAND JC, PARKS WC, PERLMUTTER DH, WETSFL RA: Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the lung and live: J Immunol 154:1861-1869, 1995
6. LACY M, JONES J, WHITTEMORE SR, HAVILAND DL, WETSEL RA, BARNUM SR: Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J Neuroimmunol 61:71-78, 1995
7. JOHNSON AR, HUGLI TE, MULLER-EBERHARD HJ: Release of histamine from rat mast cells by complement peptides C3a and C5a. (abstract) Immunology 28:1067, 1975
8. OKUSAWA S, DINARELLO CA, YANCEY KB, ENDRES S, LAWLEY TJ, FRANK MM, BURRE JF, GELFAND JA: C5a induction of human interleukin-1 synergistic effect with endotoxin or interferon-gamma. J Immunol 139:2635-2640, 1987
9. SCHOLZ W, MCCLURG MR, CARDENAS GJ, SMITH M, NOONAN DJ, HUGLI TE, MORGAN EL: C5a mediated release of interleukin-6 by human monocytes. Clin Immunol Immunopathol 57:297-307, 1990
10. EMBER JA, SANDERSON SD, HUGLI TE, MORGAN EL: Induction of IL-8 synthesis by human C5a anaphylatoxin. Am J Pathol 144:393-403, 1994
11. OKUSAWA S, YANCEY KB, VAN DER MEER JW, ENDRIES S, LONNEMANN G, HEFTER K, FRANK MM, BURKE JF, DINARELIO CA, GELFAND JA: C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro: Comparison with secretion of interleukin-1b and interleukin-1a. J Exp Med 168:443-448, 1988
12. MULLIGAN MS, SCHMID E, TILL GO, HUGLI TE, FRIEDL HP, ROTH RA, WARD PA: C5a-dependent up-regulation in vivo of lung vascular P-selectin. J Immunol 158:1857-1861, 1997
13. FOREMAN KE, VAPORICIYAN AA, BONISH BK, JONES ML, JOHNSON KJ, GLOVSKY MM, EDDY SM, WARD PA: C5a induced expression of P-selectin in endothelial cells. J Clin Invest 94:1147-1155, 1994
14. MULLIGAN MS, SCHMID E, BECK-SCHIMMER B, TILL GO, FRIEDL HP, BRAUER RB, HUGLI TE, MIYASAKA M, WARNER RL, JOHNSON KJ, WARD PA: Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest 98:503-512, 1996
15. MARCHANT A, TIELEMANS C, HUSSON C, GASTALDELLO K, SCHURMANS T, DE GROTTE D, DUCHOW J, VANHERWEGHEM L, GOLDMAN M: Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: Role of complement activation. Nephrol Dial Transplant 11:657-662, 1996
16. COMBE C, POURTEIN M, DE PRECIGOUT V, BAOUEY A, MOREL D, POTAUX L, VINCENDEAU P, BEZIAN JH, APARICIO M: Granolucyte activation and adhesion molecules during hemodialysis with cuprophane and high-flux biocompatible membranes. Am J Kidney Dis 24:437-442, 1994
17. MCCOY, HAVILAND DL, MOLMENTI EP, ZIAMBARAS T, WETSEL RA, PERLMUTTER DH: N-formylpeptide and complement C5a receptors are expressed in the liver cells and mediate hepatic acute phase gene regulation. J Exp Med 183:207-217, 1995
18. HAVILAND DL, MCCOY RL, WHITEHEAD WT, AKAMA H, MOLMENTI EP, BROWN A, HAVILAND JC, PARKS WC, PERLMUTTER DH, WETSEL RA: Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 154:1861-1869, 1995
19. MCLEAN RH: Complement and glomerulonephritis-An update. Pediatr Nephrol 7:226-232, 1993
20. JOHNSON RJ: Involvement of complement in renal disease. Curr Opin Nephrol Hypertens 6:120-127, 1997
21. SALANT DJ, BELOK S, MADAIO MP, COUSER WG: A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66:1339-1350, 1980
22. SAVIN VJ, JOHNSON RJ, COUSER WG: C5b-C9 increases albumin permeability of isolated glomeruli in vitro. Kidney Int 46:382-387, 1994
23. OGAWA T, YORIOKA N, YAMAKIDO M: Immunohistochemical studies of vitronectin. C5b-C9, and vitronectin receptor in membranous nephropathy. Nephron 70:353-358, 1995
24. MORGAN BP: Complement membrane attack complex on nucleated cells: Resistance, recovery, and non-lethal effects. Biochem J 264:1-14, 1989
25. BRADY HR, DENTON MD, JIMENEZ W, TAKATA S, PALLISER D, BRENNER BM: Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injury. Kidney Int 42:480-487, 1992
26. SUNDSTROM C, NILSSON K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17:565-577, 1976
27. FINTER NB: Dye uptake methods for assessing viral cytopathogenicity and their application to Interferon assays. J Gen Virol 5:419-427, 1969
28. YAMANKA N: Development of the glomerular mesangium. Pediatr Nephrol 2:85-91, 1988
29. SARIOLA H, TIMPL R, VON DER MARK K, MAYNE R, FITCH JM, LINSENMAYER TF, EKBLOM P: Dual origin of the glomerular basement membrane. Dev Biol 101:86-96, 1984
30. BERNSTEIN J, CHENG F, ROSZKA BS: Glomerular differentiation in metanephric culture. Lab Invest 45:183-190, 1981
31. DUBEY RK, JACKSON EK, RUPPRFCHT HD, STERZEL RB: Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens 6:88-105, 1997
32. HOLTHOFER H, SAINIO K, MIETTINEN A: The glomerular mesangium: Studies of its developmental origin and markers in vivo and in vitro. APMIS 103:354-366, 1995
33. BRANDT J, PIPPIN J, SCHULZE M, HANSCH GM, ALPERS CE, JOHNSON RJ, GORDON K, COUSER WG: Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 49:335-343, 1996
34. ROLLINS BJ: Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2:198-204, 1986
35. LLOYD CM, MINTO AW, DORF ME, PROUDFOOT A, WELLS TN, SALANT DJ, GUTIERREZ-RAMOS JC: RANTES and monocyte chemoattractant protein-1 (MCP-2) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185:1371-1380, 1997
36. MOXEY-MIMS MM, NIELSON L, NOBEL B, LWEBUGA-MUKASA JS: Monocyte chemoattractant protein-1 in chronic proliferative immune complex nephritis. Clin Immunol Immunopathol 80:123-128, 1996
37. ZOJA C, LIU XH, DONADELLI R, ABBATE M, TESTA D, CORNA D, TARABOLETTI G, VECCHI A, DONG QG, ROLLIN BJ, BERTANI T, REMUZZI G: Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol 8:720-729, 1997
38. DANIEL TO, KUMJIAN DA: Platelet-derived growth factor in renal development and disease. Semin Nephrol 13:87-95, 1993
39. BETSHOLTZ C, RAINKS EW: Platelet-derived growth factor: A key regulator of connective tissue in cells in embryogenesis and pathogenesis. Kidney Int 51:1361-1369, 1997
40. GESUALDO L, RANIERI E, PANNARALE G, DI PAOLO S, SCHENA FP: Platelet-derived growth factor and proliferative glomerulonephritis. Kidney Int 539:586-589, 1993
41. GESUALDO L, PINZANI M, FLORIANO JJ, HASSAN MO, NAGY NU, SCHENA FP: Platelet derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167, 1991
42. IIDA H, SEIFERT R, ALPERS CE, GRONWALD RG, PHILLIPS PE, PRITZL P, GORDON K, GOWN AM, Ross R, BOWEN-POPE DF, JOHNSON RJ: Platelet-derived growth factor (PDGF) and PGDF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88:5660-5664, 1991